Summary:
Columbus Clinical Research is conducting a randomized, double-blind, chronic dosing (4 weeks), four-period, five-treatment, incomplete block, cross-over, multi-center study to assess the efficacy and safety of four doses of an investigational medication relative to placebo MDI in adult subjects with mild to moderate persistent asthma.
Qualified Participants May Receive:
Compensation may be available for time and travel.